Vitamin E, its beneficial role in diabetes mellitus (DM) and its complications

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 10, 2012, Pages 1624-1628

  Jain, Anand Baburao ^a   Jain, Vaishali Anand ^b  

^a CHETTINAD HOSPITAL AND RESEARCH INSTITUTE   (India)

^b MAHSA University Bandar Saujana Putra   (Malaysia)

Author keywords

Antioxidant; Diabetes mellitus; Diabetic complications

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; VITAMIN SUPPLEMENTATION;

EID: 84871916836     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/4791.2625     Document Type: Article

References (17)

1. Bambolkar S, Sainani GS. The evaluation of oxidative stress in diabetes with or without vascular complications. J Assoc Physicians India.1995;43:10-12.
2. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, third edn, 1999 Oxford University Press, UK.
3. Parks E, Traber MG. The mechanisms of the vitamin E regulation: the research over the past decade and the focus on the future. Antioxid Redox Signal. 2000; 2:405-12.
4. Maxwell SRJ. The prospects for the use of antioxidant therapies. Drugs 1995;49(3):345-61.
5. Horwitt MK. The promotion of vitamin E. J Nutrition. 1986 Jul;116:1371-77.
6. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system Analyst 1972;97:142.
7. Allain CC., Poon LS, Chan C.S.G. The enzymatic determination of total serum cholesterol. Clin. Chem. 1974; 20: 470-75.
8. Kuznetsov NS, et al. The use of antioxidants (alpha tocopherol) in the treatment of diabetes mellitus. Probl Endokrinol Mask. 1993;39(2):9-11.
9. Raheja BS. Diabetes and atherosclerosis as immune inflammatory disorders: the options for the reversal of the disease processes. J Assoc Physicians India.1994;42:385-390,395-6.
10. Jain S, et al. The effects of a low dose omega 3 fatty acid substitution in type 2 diabetes mellitus with special reference to the oxidative stress. A prospective preliminary study. J Assoc Physicians of India. 2002;50:1028-33.
11. Stephens NG, et al. A randomised controlled trial of vitamin E in patients with coronary disease: the Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-86.
12. Stampfer MJ et al. Vitamin E consumption and the risk of coronary artery disease in women. N Engl J Med 1993;328:1444-49.
13. Narang APS, et al. The role of oxidant stress in diabetic retinopathy. Indian Medical Gazette. 2002:1-2.
14. Devaraj S, Jialal I. The low-density lipoprotein postsecretory modification, the monocyte function, and the circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of the alpha-tocopherol supplementation. Circulation. 2000;102:191-6.
15. Devaraj S, Jialal I. Alpha tocopherol supplementation decreases the serum C reactive protein and the monocyte interleukin-6 levels in normal volunteers and in type 2 diabetic patients. Free Rad Biol Med 2000; 29:790-2.
16. Upritchard JE, Sutherland WHF, Mann JI. The effect of the supplementation with tomato juice, vitamin E and vitamin C on the LDL oxidation and the products of the inflammatory activity in type 2 diabetes. Diabetes Care. 2000; 23:733-8.
17. Bursell S-E, Clermont AC, Aiello LP, Aielllo LM, Schlossman DK, Feener EP, et al., Laffel L, King GL. A high-dose vitamin E supplementation normalizes the retinal blood flow and the creatinine clearance in the patients with type 1 diabetes. Diabetes Care. 1999; 22:1245-51.